TOR THERAPEUTICS

Serial Number 97208554
606

Registration Progress

Application Filed
Jan 7, 2022
Under Examination
Jan 17, 2023
Approved for Publication
Nov 22, 2022
Published for Opposition
Nov 22, 2022
Registered

Trademark Image

TOR THERAPEUTICS

Basic Information

Serial Number
97208554
Filing Date
January 7, 2022
Published for Opposition
November 22, 2022
Abandonment Date
February 19, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 19, 2024
Classes
005

Rights Holder

TOR Therapeutics, Inc.

03
Address
925 Dale Road
Meadowbrook, PA 19046

Ownership History

TOR Therapeutics, Inc.

Original Applicant
03
Meadowbrook, PA

TOR Therapeutics, Inc.

Owner at Publication
03
Meadowbrook, PA

Legal Representation

Attorney
J. Mark Dickison

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

29 events
Date Code Type Description Documents
Feb 20, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Feb 19, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 29, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 28, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 26, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 28, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 28, 2023 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Aug 28, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 28, 2023 PETG O PETITION TO REVIVE-GRANTED Loading...
Aug 28, 2023 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Aug 28, 2023 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Aug 28, 2023 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Aug 28, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 28, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 21, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 21, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 17, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 17, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 22, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 22, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 2, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 17, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 17, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 17, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 17, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 17, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 13, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 14, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 11, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and products for the prevention and treatment of neoplastic, autoimmune, inflammatory immunological, degenerative, aging, vascular and metabolic diseases, disorders and conditions

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"